3-D Matrix: Change report (exemption share certificates, etc.)
3-D Matrix: Notice regarding the monthly exercise status of the 39th Stock Acquisition Rights (with exercise price amendment clause)
3-D Matrix: Notice of business partnership with Sumisho Pharma International
3-D Matrix: Notice of commencement of physician-led specific clinical research (multi-center joint research) targeting colorectal diverticular hemorrhage
3-D Matrix: Change report.
3-D Matrix: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
3-D Matrix: Change Report
3-D Matrix: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
3-D Matrix: Change Report
3-D Matrix: Notice regarding the monthly exercise status of the 39th Stock Acquisition Rights (with exercise price amendment clause)
3-D Matrix: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
3-D Matrix: Change Report
3-D Matrix: Interim report
3-D Matrix: Notice regarding the recording of non-operating expenses
3-D Matrix: Summary of Financial Results for the 1st Quarter Ending April 2025 [Japanese GAAP] (Consolidated)
3-D Matrix: Change report.
3-D Matrix: Notice regarding the monthly exercise status of the 39th Stock Acquisition Rights (with exercise price amendment clause)
3-D Matrix: Change report.
3-D Matrix: Change report.
3-D Matrix: Change report.
No Data
No Data